5/26/2016

Bupropion Hydrochloride 24 Hour extended Release Tablets

Products Affected - Description

- Bupropion hydrochloride 24 hour extended-release tablets, Mylan, 150 mg, 90 count, NDC 00378-2008-77

Reason for the Shortage

- Actavis transitioned to new NDC numbers, starting February 2015.
- Par states the reason for the shortage was increased demand of product.

Available Products

- Bupropion hydrochloride 24 hour extended-release tablets, Actavis, 150 mg, 30 count, NDC 45963-0141-30
- Bupropion hydrochloride 24 hour extended-release tablets, Actavis, 150 mg, 90 count, NDC 45963-0141-90
- Bupropion hydrochloride 24 hour extended-release tablets, Actavis, 300 mg, 30 count, NDC 45963-0142-30
- Bupropion hydrochloride 24 hour extended-release tablets, Global, 150 mg, 30 count, NDC 00115-6811-08
- Bupropion hydrochloride 24 hour extended-release tablets, Global, 150 mg, 90 count, NDC 00115-6811-10
- Bupropion hydrochloride 24 hour extended-release tablets, Mylan, 300 mg, 500 count, NDC 00378-2009-05
- Bupropion hydrochloride 24 hour extended-release tablets, Mylan Institutional, 150 mg, unit-dose 100 count, NDC 51079-0047-20
- Bupropion hydrochloride 24 hour extended-release tablets, Mylan Institutional, 300 mg, unit-dose 30 count, NDC 51079-0109-03
- Bupropion hydrochloride 24 hour extended-release tablets, Par Pharmaceuticals, 150 mg, 30 count, NDC 10370-0101-03
- Bupropion hydrochloride 24 hour extended-release tablets, Par Pharmaceuticals, 150 mg, 500 count, NDC 10370-0101-50
- Bupropion hydrochloride 24 hour extended-release tablets, Par Pharmaceuticals, 300 mg, 30 count, NDC 10370-0102-03
- Bupropion hydrochloride 24 hour extended-release tablets, Par Pharmaceuticals, 300 mg, 500 count, NDC 10370-0102-50
- Forfivo XL, Edgemont, 450 mg, 30 count, NDC 49909-0010-30
- Wellbutrin XL, Valeant, 150 mg, 30 count, NDC 00187-0730-30
- Wellbutrin XL, Valeant, 150 mg, 90 count, NDC 00187-0730-90
- Wellbutrin XL, Valeant, 300 mg, 30 count, NDC 00187-0731-30

Estimated Resupply Dates

- Mylan has bupropion XL 150 mg tablets in 90 count size on back order and the company estimates a release date in late-July 2015.

Updated

Updated May 26, 2016 by Michelle Wheeler, PharmD, Drug Information Specialist. Created May 7, 2014 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.